Evidence map›Paper›PMID 31214164›Full record

ArticleFrontiers in immunology2019

High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity.

Ralf Willebrand, Ibrahim Hamad, Lauren Van Zeebroeck, Máté Kiss, Kirsten Bruderek, Anneleen Geuzens, Dries Swinnen, Beatriz Fernandes Côrte-Real, Lajos Markó, Els Lebegge and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Ralf WillebrandVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, Belgium.
Ibrahim HamadVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, Belgium.
Lauren Van ZeebroeckVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, Belgium.
Máté KissCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.
Kirsten BruderekResearch Division, Department of Otorhinolaryngology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Anneleen GeuzensVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, Belgium.
Dries SwinnenVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, Belgium.
Beatriz Fernandes Côrte-RealVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, Belgium.
Lajos MarkóExperimental and Clinical Research Center, A Joint Cooperation of Max Delbrück Center for Molecular Medicine and Charité University Medicine Berlin, Berlin, Germany.
Els LebeggeCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.
Damya LaouiCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.
Josephine KemnaInstitute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thomas KammertoensInstitute of Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sven BrandauResearch Division, Department of Otorhinolaryngology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Jo A Van GinderachterCellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.
Markus KleinewietfeldVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research, University of Hasselt, Campus Diepenbeek, Hasselt, Belgium.
Hasselt University · BEEssen University Hospital · DEMax Delbrück Center · DEVIB-UGent Center for Inflammation Research · BEVrije Universiteit Brussel · BECharité - Universitätsmedizin Berlin · DE

Funding

European Research Council
6 · The paper itself

Abstract

Excess salt intake could affect the immune system by shifting the immune cell balance toward a pro-inflammatory state. Since this shift of the immune balance is thought to be beneficial in anti-cancer immunity, we tested the impact of high salt diets on tumor growth in mice. Here we show that high salt significantly inhibited tumor growth in two independent murine tumor transplantation models. Although high salt fed tumor-bearing mice showed alterations in T cell populations, the effect seemed to be largely independent of adaptive immune cells. In contrast, depletion of myeloid-derived suppressor cells (MDSCs) significantly reverted the inhibitory effect on tumor growth. In line with this, high salt conditions almost completely blocked murine MDSC function

Indexed as

ImmunityAnimalsApoptosisBiomarkersDisease Models, AnimalDisease ProgressionHeterograftsHumansImmunohistochemistryMiceMyeloid-Derived Suppressor CellsNeoplasmsSodium Chloride, DietaryBiomarkersSodium Chloride, Dietarycancercancer immunotherapydietary factorMDSCsodium chloride (dietary)

Identifiers

PMID31214164
PMCPMC6557976
OpenAlexW2948788751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.